Dr. George Yancopoulos on Saturday discussed his company’s experimental antibody treatment, Regeneron, that was administered to U.S. President Donald Trump after he tested positive for COVID-19, saying it was “validating” to see Trump’s medical team decide to administer the drug.
He went on to explain that in patients who need the drug “the most,” those who have the highest levels of virus in their body and whose own immune response was doing “the poorest job,” would see the antibody cocktail work as a boost or substitute.
Yancopoulos said that he would give the drug to himself or to a loved one, saying that’s the standard the company sets when determining if something has the potential to be effective, though he admitted he was biased as he was co-founder.
For more info, please go to 50/trump-coronavirus-very-concerning/
Subscribe to Global News Channel HERE:
Like Global News on Facebook HERE:
Follow Global News on Twitter HERE:
Follow Global News on Instagram HERE:
#GlobalNews #COVID19 #coronavirus #DonaldTrump
